Propionibacterium acnes infection induces upregulation of inflammatory genes and cytokine secretion in prostate epithelial cells
© Drott et al; licensee BioMed Central Ltd. 2010
Received: 26 May 2009
Accepted: 26 April 2010
Published: 26 April 2010
The immune stimulating bacterium Propionibacterium acnes is a frequent colonizer of benign and malignant prostate tissue. To understand the pathogenesis of the earliest phase of this infection, we examined the P. acnes triggered immune response in cultivated prostate epithelial cells.
Prostate epithelial cells are triggered to secrete IL-6, IL-8 and GM-CSF when infected with P. acnes. The secretion of cytokines is accompanied by NFκB related upregulation of the secreted cytokines as well as several components of the TLR2-NFκB signaling pathway.
P. acnes has potential to trigger a strong immune reaction in the prostate glandular epithelium. Upon infection of prostate via the retrograde urethral route, the induced inflammatory reaction might facilitate bacterial colonization deeper in the prostate tissue where persistent inflammation may impact the development of prostate diseases as hyperplasia and/or malignancy.
Asymptomatic histological inflammation is a common feature when prostate tissue is subjected to morphological examination. Varying degree of inflammation is present at both benign (prostatic hyperplasia) and malignant (neoplasia) conditions. A growing amount of research supports the idea that chronic prostatic inflammation contributes to gradual transition of normal epithelial cells to malignant cells . For example, many of the gene-variants linked to familiar prostate cancer code for proinflammatory cytokines and chemokines . A plethora of microorganisms have been evaluated for their possible involvement in the etiology of prostate inflammation. Many studies purported E. coli and sexually transmitted agents as likely candidates capable of inducing chronic prostatic inflammation [3–5]. A Gram-positive bacterium; Propionibacterium acnes (P. acnes) has been reported to be frequently present in various prostatic diseases (as reviewed in ) and its presence has been correlated to inflammation in prostate cancer specimens [7–9]. P. acnes, a well studied pathogenetic factor in cutaneous disorders like acne vulgaris, has been demonstrated to stimulate monocytes and endothelial cells to secrete pro-inflammatory cytokines via activation of Toll-like receptor (TLR) 2 [10, 11]. In this study we present an in vitro model to study the inflammatory response of prostate derived epithelial cells to P. acnes infection. We report that P. acnes induces upregulation of numerous pro-inflammatory substances at the mRNA level accompanied by secretion of respective soluble substances such as interleukins 6, 8 and GM-CSF. Components of the TLR2-NFκB signaling pathway were upregulated, suggesting an involvement of this particular pathway for the response. Blocking of the TLR2 with monoclonal antibodies partly reduced the effects.
Pilot studies to define experimental conditions for P. acnes infection of epithelial cells
Secretion of cytokines is one of the end results of innate immune response at a cellular level. We therefore assessed the secretion of three key cytokines, IL-6, IL-8 and GM-CSF (also called CSF-2) from the prostate-derived epithelial cell-line RWPE-1 in response to infection with P. acnes. To set experimental conditions as multiplicity of infection (MOI) and useful infection time, we defined the desired criteria as maximal cytokine secretion after 48 h and no visual cellular detachment or cell-death. A MOI of 16-40:1 fulfilled these criteria (data not shown). We therefore decided to use a MOI of 16:1 for the following experiments.
Prostate epithelial cells secrete IL-6, IL-8, and GM-CSF in response to Propionibacterium acnes infection
P. acnes induced secretion of IL-8 is partially blocked by α-TLR-2 antibodies
P. acnes infection induces up-regulation of several cytokines and components of the TLR-2 signaling pathway
List of genes that are upregulated upon P. acnes infection.
Chemokine (C-C motif) ligand 2
Colony stimulating factor 2 (granulocyte-macrophage)
Colony stimulating factor 3 (granulocyte)
Chemokine (C-X-C motif) ligand 10
Interferon, beta 1, fibroblast
Interleukin 1, alpha
Interleukin 6 (interferon, beta 2)
Interleukin-1 receptor-associated kinase 2
Interferon regulatory factor 1
Lymphotoxin alpha (TNF superfamily, member 1)
Nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100)
Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha
V-rel reticuloendotheliosis viral oncogene homolog
V-rel reticuloendotheliosis viral oncogene homolog A,
Receptor-interacting serine-threonine kinase 2
Toll-like receptor 2
Tumor necrosis factor (TNF superfamily, member 2)
Toll-like receptor adaptor molecule 1
List of genes that are downregulated upon P. acnes infection.
V-fos FBJ murine osteosarcoma viral oncogene homolog
High-mobility group box 1
Toll-like receptor 4
Ubiquitin-conjugating enzyme E2 variant 1
Prostate specimens commonly display signs of chronic histological inflammation, along with occasional acute inflammation. Numerous studies have explored a possible link between prostate inflammation and cancer development and recent reviews of epidemiologic, genetic, and molecular studies have collectively suggested that the two cellular processes may indeed interact [2, 14–16]. Exposure to environmental factors such as infectious agents can lead to injury of the prostate and to the development of chronic inflammation . The intrinsic interplay between microbes and urogenital cells is a key feature in the understanding of the microbial involvement in prostate disease. Both Chlamydia and Mycoplasma have been demonstrated to induce IL-6 and IL-8 production in immortalized normal prostate epithelial cells (PNT2) [18, 19]. Given the emergence of P. acnes as an infecting agent in prostate tissue [7–9] we investigated the effect of the bacterium on prostate epithelial cells of non-malignant origin (RWPE-1). In vitro, P. acnes induced considerable secretion of IL-6 and IL-8 and, to a lesser extent, GM-CSF. Secretion of IL8 was shown to be mediated via TLR2, as the receptor blockage with anti-TLR2 monoclonal antibodies reduced its secretion. In contrast, we did not observe any significant reduction in secretion of IL-6 and GM-CSF by blockage of TLR2. Earlier reports present evidence that P. acnes is able to stimulate monocytes and endothelial cells to secrete pro-inflammatory cytokines via activation of TLR2 [10, 11]. Our results partly confirm this. Even toll-like receptors 4 and 9 have been implicated in P. acnes mediated immune modulatory effects . Both human and rat prostate epithelial cell lines are known to express TLR2, TLR4, and TLR9 [21, 22] and since blockage of TLR2 in our experiment has not totally inhibited cytokine secretion, the involvement of other TLR may also be hypothesized. However, possible TLR4 involvement is compromised by the observed downregulation of the gene expression. Another mechanism may involve auto inducing capability of the released cytokines that generates a self-perpetuating inflammatory process.
The increased secretion of such cytokines was accompanied by concordant mRNA up-regulation. Moreover, the broader analysis of inflammation associated genes revealed that chemokine ligands and pro-inflammatory substances CCL2, CXCL10, TNF-α, TNF-β (lymphotoxin-α), CSF3, IL1-α, and IFN-β were also significantly upregulated. Further studies are required to determine if upregulation of aforementioned genes is accompanied by enhanced cytokine production by prostate epithelial cells. The upregulation of the transcriptional regulators JUN, REL, RIPK2, NFKB2, NFKBIA, IRF1, IRAK2 and the TLR/IL1-receptor co-factor TICAM1 is coherent with earlier studies of TLR2 signaling cascade leading to Fib activation [23, 24].
Secretion of IL-6, IL-8 and GM-CSF are central for recruitment and differentiation of macrophages and neutrophils in inflamed tissue [25–27]. A prolonged time of increased cytokine levels might have adverse effects on the tissue. P. acnes induced elevation of IL-8 expression in hair-follicle endothelial cells is associated with epidermal hyperplasia and follicular hyperkeratosis in acne vulgaris and psoriasis [28, 29]. There is also a correlation between the more pronounced IL-8 expression and dermal angiogenesis . Interestingly, both IL-6 and IL-8 have been suggested as contributors to prostate cancer development. The expression of IL-6 and its receptor has been demonstrated in clinical specimens of both prostate cancer and benign prostate hyperplasia , and levels of IL-6 increase in organ-confined tumors . In vitro experiments have shown that IL-6 may play a role in prostate cancer cell growth and differentiation and that it stimulates cell growth of malignant cells . Following prolonged treatment with IL-6, prostate cancer cells can alter the responsiveness to the cytokine and acquire the ability to proliferate at a higher rate and become more tumorigenic [33, 34]. IL-8 has been shown to increase the transcriptional activity of the androgen receptor in prostate cancer cell lines, suggesting a potential role of this chemokine in modulating the transition of prostate cancer to an androgen-independent state . Other studies report that IL-8 contribution to prostate cell proliferation is independent of the androgen receptor . Our data indicate that the prostate epithelium significantly contributes to locally increased levels of both IL-6 and IL-8 when infected with P. acnes, thus potentially promoting adverse effects as increased proliferation and angiogenic activities by autocrine and/or endocrine mechanisms. The pathogenesis of P. acnes in locations other than the hair-follicle is still poorly understood. We currently address questions about its involvement in prostate disease such as prevalence, genetic variability and impact on histological inflammation and neoplasia (Elgh et al., manuscripts in preparation).
In conclusion, we demonstrate that prostate epithelial cells secrete inflammatory cytokines in response to P. acnes, partly through a TLR2-mediated mechanism. We propose that this strong immune-stimulating effect facilitates the bacterial colonization deeper into the prostate tissue where P. acnes can form long-lasting biofilm-like aggregates . A possible mechanism may involve intracellular transport in recruited macrophages, as P. acnes has been demonstrated to withstand degradation by phagocytosing mononuclear cells .
Prostate cell lines
RWPE-1, human prostate epithelial cell line (ATCC© CRL-11609) was maintained in complete KSF-medium supplemented with 5 ng/l EGF, 0.05 mg/l BPE and 100 U/ml PEST (GIBCO BRL/Life technologies, Inc., Gaithersburg, MD, USA).
Cells were split 1:5, 1-2 times per week using 0,05% (w/v) trypsin/EDTA (GIBCO BRL/Life technologies, Inc., Gaithersburg, MD, USA). Cells were maintained in a humidified incubator at 37C containing 5% CO2.
P. acnes, serotype 1a, isolated from craniopharyngeom fluid was grown in Brain-Heart Infusion Broth + 5% horse serum at 37C under microaerobic conditions. The bacteria were grown to a density of 109 per ml, pelleted and resuspended into sterile PBS.
RWPE-1 cells were seeded into 24-well plates at a density of 1 × 105cells per well in one ml normal growth medium. After 48 h, cells were washed in PBS and the medium was changed to DMEM without FCS and PEST. Cells were infected with P. acnes at a MOI of 16:1 and immediate close contact between bacteria and cells was achieved by centrifugation of the flask for 10 min at 700 g. Non-infected cells were used as controls.
For the TLR2 blocking experiments, RWPE-1 cells were pre-treated with mouse anti-mouse/human TLR2 mAb (clone T2.5  cat.code: mab-mtrl2, InVivoGen, San Diego, USA) at the concentration 100 ng/ml for 1 h. The cells were then infected with P. acnes as described above.
Supernatants were harvested after 24 h and 48 h. Supernatants were cleared from particles by centrifugation 10 min at 12000 g, stored at -20C and later assayed for IL-6, IL-8 and GM-CSF by ELISA (R&D systems, Minneapolis, Minnesota) according to manufacturer's instruction.
RNA preparation and Reverse Transcription PCR
Cells were seeded at a density of 1 × 106 in a 25 cm2 culture flask in normal growth medium. After 48 h, cells were washed in PBS and the medium were changed to DMEM without FCS and PEST. Cells were infected with P. acnes at a MOI of 16:1 and immediate close contact between bacteria and cells were achieved by centrifugation of the flask for 10 min at 700 g. Total RNA was prepared after 0 h and 24 h using RNeasy Mini kit (Qiagen, Hilden, Germany) with the on-column DNase treatment step according to manufacturer's instruction. Cells were trypsinised using 0,05% (w/v) trypsin/EDTA, lysed in 350 μl RTL buffer and homogenized in a TissueLyser with Stainless steel Beads, 5 mm (Qiagen, Hilden, Germany).
RNA concentration and purity were assessed in a NanoDrop© ND-1000 spectrophotometer (Thermo scientific, Wilmington, USA) at A260 and the ratios of A260:A230 and A260:280.
Complementary DNA (cDNA) was generated from one μg total RNA using RT2 First strand kit (SABiosciences, Frederick, MD, USA) according to the manufacturer's instruction. Quality of the cDNA was verified by PCR array housekeeping genes: beta-2-microglobulin, hypoxanthine phosphoribosyltransferase 1, ribosomal protein L13a, glyceraldehyde-3-phosphate dehydrogenase, beta-actin using primers from (SABiosciences, Frederick, MD, USA).
Real-time Quantitative PCR
Gene expression analysis measuring transcription of 84 inflammation associated genes was conducted using the RT2 Profiler PCR Array, Human Toll-Like Receptor Signaling Pathway PAHS-018A (SABiosciences, Frederick, MD, USA) according to manufacturer's instruction. Real-time PCR detection was performed with an IQ™5 instrument (Bio-Rad, Hercules, CA, USA).
Complete list of genes analyzed by the array can be found at: http://www.SABiosciences.com
Relative gene expression was calculated with the ΔΔCt method in the web-based software package for RT2 Profiler PCR array systems (SABiosciences, Frederick, MD, USA).
Due to the small sample size (n = 3), a permutation test was used to test possible regulation . A null hypothesis corresponding to no regulation was tested for each gene and each protein concentration and rejected for p = 0.05.
Grant sponsor: Kempestiftelserna (OA, FE, JO); Grant sponsor: Lions Cancer Research Foundation and Cancerforskningsfonden Norrland (JO). Grant sponsor: Percy Falks stiftelse för forskning beträffande prostatacancer och bröstcancer (JO). We thank Dr. Anna Fahlgren for critical reading of the manuscript.
- De Marzo AM, Platz EA, Sutcliffe S, Xu J, Gronberg H, Drake CG, Nakai Y, Isaacs WB, Nelson WG: Inflammation in prostate carcinogenesis. Nat Rev Cancer. 2007, 7 (4): 256-269. 10.1038/nrc2090.PubMed CentralView ArticlePubMedGoogle Scholar
- Sun J, Turner A, Xu J, Gronberg H, Isaacs W: Genetic variability in inflammation pathways and prostate cancer risk. Urol Oncol. 2007, 25 (3): 250-259.View ArticlePubMedGoogle Scholar
- Krieger JN, Riley DE, Vesella RL, Miner DC, Ross SO, Lange PH: Bacterial dna sequences in prostate tissue from patients with prostate cancer and chronic prostatitis. J Urol. 2000, 164 (4): 1221-1228. 10.1016/S0022-5347(05)67145-5.View ArticlePubMedGoogle Scholar
- Hochreiter WW, Duncan JL, Schaeffer AJ: Evaluation of the bacterial flora of the prostate using a 16S rRNA gene based polymerase chain reaction. J Urol. 2000, 163 (1): 127-130. 10.1016/S0022-5347(05)67987-6.View ArticlePubMedGoogle Scholar
- Sfanos KS, Sauvageot J, Fedor HL, Dick JD, De Marzo AM, Isaacs WB: A molecular analysis of prokaryotic and viral DNA sequences in prostate tissue from patients with prostate cancer indicates the presence of multiple and diverse microorganisms. Prostate. 2008, 68 (3): 306-320. 10.1002/pros.20680.View ArticlePubMedGoogle Scholar
- Alexeyev O, Olsson J, Elgh F: Is there evidence for a role of Propionibacterium acnes in prostatic disease?. Urology. 2009, 73 (2): 220-224. 10.1016/j.urology.2008.02.052.View ArticlePubMedGoogle Scholar
- Alexeyev OA, Marklund I, Shannon B, Golovleva I, Olsson J, Andersson C, Eriksson I, Cohen R, Elgh F: Direct visualization of Propionibacterium acnes in prostate tissue by multicolor fluorescent in situ hybridization assay. J Clin Microbiol. 2007, 45 (11): 3721-3728. 10.1128/JCM.01543-07.PubMed CentralView ArticlePubMedGoogle Scholar
- Alexeyev O, Bergh J, Marklund I, Thellenberg-Karlsson C, Wiklund F, Gronberg H, Bergh A, Elgh F: Association between the presence of bacterial 16S RNA in prostate specimens taken during transurethral resection of prostate and subsequent risk of prostate cancer (Sweden). Cancer Causes Control. 2006, 17 (9): 1127-1133. 10.1007/s10552-006-0054-2.View ArticlePubMedGoogle Scholar
- Cohen RJ, Shannon BA, McNeal JE, Shannon T, Garrett KL: Propionibacterium acnes associated with inflammation in radical prostatectomy specimens: a possible link to cancer evolution?. J Urol. 2005, 173 (6): 1969-1974. 10.1097/01.ju.0000158161.15277.78.View ArticlePubMedGoogle Scholar
- Kim J: Review of the innate immune response in acne vulgaris: activation of Toll-like receptor 2 in acne triggers inflammatory cytokine responses. Dermatology. 2005, 211 (3): 193-198. 10.1159/000087011.View ArticlePubMedGoogle Scholar
- Vowels BR, Yang S, Leyden JJ: Induction of proinflammatory cytokines by a soluble factor of Propionibacterium acnes: implications for chronic inflammatory acne. Infect Immun. 1995, 63 (8): 3158-3165.PubMed CentralPubMedGoogle Scholar
- Cumming G, Fidler F, Vaux DL: Error bars in experimental biology. J Cell Biol. 2007, 177 (1): 7-11. 10.1083/jcb.200611141.PubMed CentralView ArticlePubMedGoogle Scholar
- Meng G, Rutz M, Schiemann M, Metzger J, Grabiec A, Schwandner R, Luppa PB, Ebel F, Busch DH, Bauer S: Antagonistic antibody prevents toll-like receptor 2-driven lethal shock-like syndromes. J Clin Invest. 2004, 113 (10): 1473-1481.PubMed CentralView ArticlePubMedGoogle Scholar
- Maitland NJ, Collins AT: Inflammation as the primary aetiological agent of human prostate cancer: a stem cell connection?. J Cell Biochem. 2008, 105 (4): 931-939. 10.1002/jcb.21843.View ArticlePubMedGoogle Scholar
- Haverkamp J, Charbonneau B, Ratliff TL: Prostate inflammation and its potential impact on prostate cancer: a current review. J Cell Biochem. 2008, 103 (5): 1344-1353. 10.1002/jcb.21536.View ArticlePubMedGoogle Scholar
- Sutcliffe S, Platz EA: Inflammation in the etiology of prostate cancer: an epidemiologic perspective. Urol Oncol. 2007, 25 (3): 242-249.View ArticlePubMedGoogle Scholar
- De Marzo AM, Nakai Y, Nelson WG: Inflammation, atrophy, and prostate carcinogenesis. Urol Oncol. 2007, 25 (5): 398-400.View ArticlePubMedGoogle Scholar
- Al-Mously N, Eley A: Interaction of Chlamydia trachomatis serovar E with male genital tract epithelium results in secretion of proinflammatory cytokines. J Med Microbiol. 2007, 56 (Pt 8): 1025-1032. 10.1099/jmm.0.47241-0.View ArticlePubMedGoogle Scholar
- Takeyama K, Mitsuzawa H, Shimizu T, Konishi M, Nishitani C, Sano H, Kunishima Y, Matsukawa M, Takahashi S, Shibata K: Prostate cell lines secrete IL-8 in response to Mycoplasma hominis through Toll-like receptor 2-mediated mechanism. Prostate. 2006, 66 (4): 386-391. 10.1002/pros.20358.View ArticlePubMedGoogle Scholar
- Jugeau S, Tenaud I, Knol AC, Jarrousse V, Quereux G, Khammari A, Dreno B: Induction of toll-like receptors by Propionibacterium acnes. Br J Dermatol. 2005, 153 (6): 1105-1113. 10.1111/j.1365-2133.2005.06933.x.View ArticlePubMedGoogle Scholar
- Kundu SD, Lee C, Billips BK, Habermacher GM, Zhang Q, Liu V, Wong LY, Klumpp DJ, Thumbikat P: The toll-like receptor pathway: a novel mechanism of infection-induced carcinogenesis of prostate epithelial cells. Prostate. 2008, 68 (2): 223-229. 10.1002/pros.20710.View ArticlePubMedGoogle Scholar
- Gatti G, Rivero V, Motrich RD, Maccioni M: Prostate epithelial cells can act as early sensors of infection by up-regulating TLR4 expression and proinflammatory mediators upon LPS stimulation. J Leukoc Biol. 2006, 79 (5): 989-998. 10.1189/jlb.1005597.View ArticlePubMedGoogle Scholar
- Takeda K, Kaisho T, Akira S: Toll-like receptors. Annu Rev Immunol. 2003, 21: 335-376. 10.1146/annurev.immunol.21.120601.141126.View ArticlePubMedGoogle Scholar
- Chen Q, Koga T, Uchi H, Hara H, Terao H, Moroi Y, Urabe K, Furue M: Propionibacterium acnes-induced IL-8 production may be mediated by NF-kappaB activation in human monocytes. J Dermatol Sci. 2002, 29 (2): 97-103. 10.1016/S0923-1811(02)00013-0.View ArticlePubMedGoogle Scholar
- Kishimoto T: Interleukin-6: from basic science to medicine--40 years in immunology. Annu Rev Immunol. 2005, 23: 1-21. 10.1146/annurev.immunol.23.021704.115806.View ArticlePubMedGoogle Scholar
- Waugh DJ, Wilson C: The interleukin-8 pathway in cancer. Clin Cancer Res. 2008, 14 (21): 6735-6741. 10.1158/1078-0432.CCR-07-4843.View ArticlePubMedGoogle Scholar
- Hamilton JA: GM-CSF in inflammation and autoimmunity. Trends Immunol. 2002, 23 (8): 403-408. 10.1016/S1471-4906(02)02260-3.View ArticlePubMedGoogle Scholar
- Gillitzer R, Berger R, Mielke V, Muller C, Wolff K, Stingl G: Upper keratinocytes of psoriatic skin lesions express high levels of NAP-1/IL-8 mRNA in situ. J Invest Dermatol. 1991, 97 (1): 73-79. 10.1111/1523-1747.ep12478128.View ArticlePubMedGoogle Scholar
- Abd El All HS, Shoukry NS, El Maged RA, Ayada MM: Immunohistochemical expression of interleukin 8 in skin biopsies from patients with inflammatory acne vulgaris. Diagn Pathol. 2007, 2: 4-10.1186/1746-1596-2-4.PubMed CentralView ArticlePubMedGoogle Scholar
- Hobisch A, Rogatsch H, Hittmair A, Fuchs D, Bartsch G, Klocker H, Bartsch G, Culig Z: Immunohistochemical localization of interleukin-6 and its receptor in benign, premalignant and malignant prostate tissue. J Pathol. 2000, 191 (3): 239-244. 10.1002/1096-9896(2000)9999:9999<::AID-PATH633>3.0.CO;2-X.View ArticlePubMedGoogle Scholar
- Giri D, Ozen M, Ittmann M: Interleukin-6 is an autocrine growth factor in human prostate cancer. Am J Pathol. 2001, 159 (6): 2159-2165.PubMed CentralView ArticlePubMedGoogle Scholar
- Culig Z, Steiner H, Bartsch G, Hobisch A: Interleukin-6 regulation of prostate cancer cell growth. J Cell Biochem. 2005, 95 (3): 497-505. 10.1002/jcb.20477.View ArticlePubMedGoogle Scholar
- Hobisch A, Ramoner R, Fuchs D, Godoy-Tundidor S, Bartsch G, Klocker H, Culig Z: Prostate cancer cells (LNCaP) generated after long-term interleukin 6 (IL-6) treatment express IL-6 and acquire an IL-6 partially resistant phenotype. Clin Cancer Res. 2001, 7 (9): 2941-2948.PubMedGoogle Scholar
- Steiner H, Godoy-Tundidor S, Rogatsch H, Berger AP, Fuchs D, Comuzzi B, Bartsch G, Hobisch A, Culig Z: Accelerated in vivo growth of prostate tumors that up-regulate interleukin-6 is associated with reduced retinoblastoma protein expression and activation of the mitogen-activated protein kinase pathway. Am J Pathol. 2003, 162 (2): 655-663.PubMed CentralView ArticlePubMedGoogle Scholar
- Seaton A, Scullin P, Maxwell PJ, Wilson C, Pettigrew J, Gallagher R, O'Sullivan JM, Johnston PG, Waugh DJ: Interleukin-8 signaling promotes androgen-independent proliferation of prostate cancer cells via induction of androgen receptor expression and activation. Carcinogenesis. 2008, 29 (6): 1148-1156. 10.1093/carcin/bgn109.View ArticlePubMedGoogle Scholar
- Araki S, Omori Y, Lyn D, Singh RK, Meinbach DM, Sandman Y, Lokeshwar VB, Lokeshwar BL: Interleukin-8 Is a Molecular Determinant of Androgen Independence and Progression in Prostate Cancer. Cancer Res. 2007, 67 (14): 6854-6862. 10.1158/0008-5472.CAN-07-1162.View ArticlePubMedGoogle Scholar
- Webster GF, Leyden JJ, Musson RA, Douglas SD: Susceptibility of Propionibacterium acnes to killing and degradation by human neutrophils and monocytes in vitro. Infect Immun. 1985, 49 (1): 116-121.PubMed CentralPubMedGoogle Scholar
- Good PI: Permutation tests: a practical guide to resampling methods for testing hypotheses. 2000, New York: Springer, 2View ArticleGoogle Scholar